Dupilumab-induced rhinitis in severe asthma patients: A case series
- PMID: 38134469
- DOI: 10.1016/j.resmer.2023.101072
Dupilumab-induced rhinitis in severe asthma patients: A case series
Conflict of interest statement
Declaration of Competing Interest Camille Taillé reports grants from GSK, Sanofi, AstraZeneca; consulting fees from GSK, AstraZeneca, Sanofi, Novartis, Chiesi, outside the present manuscript. The rest of the authors declare that they have no relevant conflicts of interest.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
